Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Atopic Dermatitis in Children

Putting guidelines into primary practice

Treatment guidelines for atopic dermatitis (AD) in children designed specifically for use by pediatricians and other primary care physicians includes basic management measures such as skin care, antiseptic measures, and trigger avoidance to be used regardless of AD severity, according to a roundtable discussion to address challenges in AD management. Recommendations for the PCP include:

• The diagnosis of eczema is a clinical one based on a chronic or relapsing course of a pruritic dermatitis consisting of erythematous papules or patches of scaling and/or excoriated skin.

• Basic management is important with skin hydration with an appropriate moisturizer, use of dilute bleach baths, trigger avoidance and acute treatment for flares.

• Treatment of acute flares is managed with topical corticosteroids, using a more potent topical steroid initially and then deescalating therapy to a less potent agent after a few days to weeks.

For patients with moderate to severe eczema, maintenance therapy for flare-prone areas should be applied regularly or at first sign of a flare-up. Recommended agents include tacrolimus or pimecrolimus (topical calcineurin inhibitors) or medium or low-potency topical corticosteroids (avoiding medium potency topical steroids on the face) depending upon the severity of eczema.

Citation: Eichenfield LF, Boguniewicz M, Simpson EL, Russell JJ, et al. Translating atopic dermatitis management guidelines into practice for primary care providers. Pediatrics. [Published online ahead of print August 3, 2015]. doi: 10.1542/peds.2014-3678.

Commentary: Eczema affects approximately 12% of children (aged 0-17 years) in the United States, most of who have mild disease and are well taken care of by primary care physicians. This article provides clear guidance for treatment of a disease that we see quite frequently. The clear recommendation for diluted bleach baths or washes based on very good evidence, an approach that is not well appreciated will, I suspect, lead to a helpful addition to the standard approach for many physicians. —Neil Skolnik, MD

This Week's Must Reads

Patient-Centered Intervention for Prostate Ca Care, J Clin Oncol; ePub 2019 Mar 12; Jayadevappa, et al

Subsequent Cancer Risk in Prostate Cancer, Lancet Oncol; ePub 2019 Mar 15; Mohamad, et al

Accuracy of 68Ga-PSMA-11 PET in Prostate Cancer, JAMA Oncol; ePub 2019 Mar 28; Fendler, et al

Low Muscle Mass in Patients with Prostate Cancer, J Urol; ePub 2019 Mar 27; Pak, Park, et al

Steroid Hormones & Progression of Prostate Cancer, Cancer Epidemiol Biomarkers Prev; ePub 2019 Mar 27; Lévesque, et al

Must Reads in Dermatology

USPSTF: Behavioral Counseling to Prevent Skin Cancer, JAMA; 2018 Mar 20; USPSTF, et al

Comparing Oral Meds for Toenail Fungal Infection, JAMA; 2018 Jan 23/30; Kreijkamp-Kaspers, et al

Do Bleach Baths Reduce Atopic Dermatitis Severity?, Ann Allergy Asthma Immunol; 2017 Nov; Chopra, et al

Pubic Hair Grooming-Related Injuries Evaluated, JAMA Dermatol; ePub 2017 Aug 16; Truesdale, et al

Atopic Dermatitis in Children , Putting guidelines into primary practice